MedPath
NMPA Approval

Sildenafil Citrate Orodispersible Tablets

国药准字H20249739

December 17, 2024

Drug Information

枸橼酸西地那非口崩片

片剂

50mg(按C₂₂H₃₀N₆O₄S计)

化学药品

December 17, 2024

Company Information

Applicant Company

珠海市金海岸生物工业区

Manufacturing Company

珠海市金湾区黄竹路268号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

枸橼酸西地那非口崩片 - NMPA 批准文号 | MedPath